Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing. Background: Small bowel adenocarcinoma is a rare malignancy with limited data to support the choice ...
Randomized phase II study of vandetanib (VAN) alone or in combination with carboplatin and paclitaxel (CP) as first-line treatment for advanced non-small cell lung cancer (NSCLC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results